Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Invicta DiagnosticNSE:INVICTA +3.88%21 Days Inventory is 76.65 as of Mar. 2026, which is 3% above its 10-year median of 74.55. GuruFocus rates NSE:INVICTA with a GF Score™ of 21/100. The stock has 3 warning signs investors should review. Among 176 Medical Diagnostics & Research companies, Invicta Diagnostic ranks worse than 53.98% on this metric.
The historical rank and industry rank for Invicta Diagnostic's Days Inventory or its related term are showing as below:
NSE:INVICTA'
s Days Inventory Range Over the Past 10 Years
Min: 73.42 Med: 74.55 Max: 128.6
Current: 74.02
During the past 3 years, Invicta Diagnostic's highest Days Inventory was 128.60. The lowest was 73.42. And the median was 74.55.
NSE:INVICTA's Days Inventory is ranked worse than 53.98% of 176
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.715
vs NSE:INVICTA: 74.02
Invicta Diagnostic's Days Inventory
increased
from Mar. 2025 (0.00) to Mar. 2026 (76.65).
It might indicate that Invicta Diagnostic's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Invicta Diagnostic's Inventory Turnover for the
six
months ended in Mar. 2026 was 2.38.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Invicta Diagnostic's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.04.
Invicta Diagnostic (NSE:INVICTA) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Invicta Diagnostic's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Invicta Diagnostic's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Invicta Diagnostic Days Inventory Related Terms
Invicta Diagnostic Days Inventory Historical Data
* Premium members only.
The historical data trend for Invicta Diagnostic's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic Days Inventory Chart
Invicta Diagnostic Annual Data
Trend
Mar24
Mar25
Mar26
Days Inventory
128.60
74.55
73.42
Invicta Diagnostic Semi-Annual Data
Mar24
Mar25
Sep25
Mar26
Days Inventory
0.00
0.00
71.96
76.65
NSE:INVICTA vs TMO, DHR, IDXX: Days Inventory Comparison
For the Diagnostics & Research subindustry, Invicta Diagnostic's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Invicta Diagnostic Days Inventory vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Invicta Diagnostic's Days Inventory distribution charts can be found below:
* The bar in red indicates where Invicta Diagnostic's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Invicta Diagnostic (NSE:INVICTA) has a Days Inventory of 76.65 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Invicta Diagnostic and its competitors. This is near median its historical median of 74.55. Over the past decade, Invicta Diagnostic's Days Inventory has ranged from 73.42 to 128.60. According to the industry distribution chart, Invicta Diagnostic ranks #95 out of 176 companies in the Medical Diagnostics & Research industry, placing it in the top 54%.
Is Invicta Diagnostic's Days Inventory too high?
Invicta Diagnostic's current Days Inventory of 76.65 is near median its 10-year median of 74.55. Over the past 10 years, this metric has ranged from a low of 73.42 to a high of 128.60. The Medical Diagnostics & Research industry median Days Inventory is 67.72. Invicta Diagnostic's value of 76.65 is 13.2% above this industry median. Based on the distribution chart, Invicta Diagnostic ranks #95 out of 176 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Invicta Diagnostic has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Invicta Diagnostic's Days Inventory compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Invicta Diagnostic ranks #95 out of 176 companies for Days Inventory. This places Invicta Diagnostic in the lower half of its industry. The industry median Days Inventory is 67.72. Invicta Diagnostic's value of 76.65 is 13.2% above this benchmark. Historically, Invicta Diagnostic's own Days Inventory has ranged from 73.42 to 128.60 over the past decade. While the company's 10-year median is 74.55 vs. the industry median of 67.72, Invicta Diagnostic has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Diagnostics & Research company?
The median Days Inventory among Medical Diagnostics & Research companies is 67.72, based on 176 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Invicta Diagnostic's current Days Inventory of 76.65 is 13.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Invicta Diagnostic and its competitors. For the Medical Diagnostics & Research industry, the median Days Inventory is 67.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Invicta Diagnostic's current Days Inventory is 76.65, which is near median its own 10-year median of 74.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Invicta Diagnostic stock overvalued right now?
Invicta Diagnostic (NSE:INVICTA) has a current Days Inventory of 76.65. The current Days Inventory is 76.65, which is near median its 10-year median of 74.55 and 13.2% above the Medical Diagnostics & Research industry median of 67.72. Invicta Diagnostic's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Invicta Diagnostic (NSE:INVICTA), the current Days Inventory is 76.65 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Invicta Diagnostic Ltd is engaged in the business of medical and diagnostic services and operates diagnostic centres providing medical testing and allied healthcare services in the Mumbai Metropolitan Region. The Company runs a diagnostic chain comprising seven diagnostic centres and one centralised laboratory across MMR in Maharashtra and operates under a hub and spoke model with a flagship hub in Thane, additional hub centres, spoke centres, and a centralised laboratory. Its service offerings include radiology and imaging, pathology and clinical laboratory tests, teleradiology, and services such as ultrasound, X Ray, CT scan, MRI scan, PET scan, and cardiac diagnostics, with patient convenience supported through home sample collection, house calls, and multiple report delivery options.
21GF Score
Get the complete analysis for NSE:INVICTA
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INVICTA has been successfully added to your 
